Usefulness of diffusion-weighted imaging for differentiating between desmoid tumors and malignant soft tissue tumors

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 1, 2011, Pages 189-193

  Oka, Kiyoshi ^a   Yakushiji, Toshitake ^a   Sato, Hiro ^a   Fujimoto, Toru ^a   Hirai, Toshinori ^a   Yamashita, Yasuyuki ^a   Mizuta, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

apparent diffusion coefficient (ADC); desmoids tumors; diffusion weighted imaging (DWI); malignant soft tissue tumor

Indexed keywords

GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DESMOID TUMOR; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SCHOOL CHILD; SOFT TISSUE TUMOR; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 78650655008     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22406     Document Type: Article

References (30)

1. Pignatti G, Barbanti-BrÃdano G, Ferrari D, et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000; 375: 207-213.
2. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF., Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 1999; 86: 2045-2052.
3. Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC., Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984; 66: 1369-1374.
4. Park HC, Pyo HR, Shin KH, Suh CO., Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure. Oncology 2003; 64: 346-352.
5. van der Hul RL, Seynaeve C, van Geel BN, Verweij J., Low dose methotrexate and vinblastine, given weekly to patients with desmoid tumours, is associated with major toxicity. Sarcoma 2003; 7: 153-157.
6. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G., High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100: 612-620.
7. Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T., Natural course of desmoid-type fibromatosis. J Orthop Sci 2008; 13: 51-55.
8. Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF., The enigma of desmoid tumors. Ann Surg 1999; 229: 866-873.
9. Redmond OM, Stack JP, Dervan PA, Hurson BJ, Carney DN, Ennis JT., Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making. Radiology 1989; 172: 811-815.
10. Rosenthal RE, Wozney P., Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging. J Magn Reson Imaging 1991; 1: 547-551.
11. Romero JA, Kim EE, Kim CG, Chung WK, Isiklar I., Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration. J Comput Assist Tomogr 1995; 19: 782-787.
12. Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G., Imaging of intra- and extraabdominal desmoid tumors. Radiographics 1991; 11: 959-968.
13. Garant M, Remy H, Just N., Aggressive fibromatosis of the neck: MR findings. AJNR Am J Neuroradiol 1997; 18: 1429-1431.
14. Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E., Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006; 186: 247-254.
15. Hartman TE, Berquist TH, Fetsch JF., MR imaging of extraabdominal desmoids: differentiation from other neoplasms. AJR Am J Roentgenol 1992; 158: 581-585.
16. Feld R, Burk DL Jr. McCue P, Mitchell DG, Lackman R, Rifkin MD., MRI of aggressive fibromatosis: frequent appearance of high signal intensity on T2-weighted images. Magn Reson Imaging 1990; 8: 583-588.
17. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M., MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407.
18. Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190: 481-488.
19. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N., Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008; 18: 486-492.
20. Manenti G, Di Roma M, Mancino S, et al. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3T. Radiol Med 2008; 113: 199-213.
21. Barile A, Zugaro L, Catalucci A, et al. Soft tissue liposarcoma: histological subtypes, MRI and CT findings. Radiol Med. 2002; 104: 140-149.
22. Provenzale JM, Mukundan S, Barboriak DP., Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006; 239: 632-649.
23. Oka K, Yakushiji T, Sato H, et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 2010; 39: 141-146.
24. Murakami R, Hirai T, Sugahara T, et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology. 2009; 251: 838-845.
25. Vandevenne JE, De Schepper AM, De Beuckeleer L, et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol 1997; 7: 1013-1019.
26. Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190: 481-488.
27. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172-178.
28. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage-the non-Hodgkin's lymphoma pathologic classification project. Cancer 1982; 49: 2112-2135.
29. Baur A, Reiser MF., Diffusion-weighted imaging of the musculoskeletal system in humans. Skel Radiol 2000; 29: 555-562.
30. Baur A, Huber A, Ertl-Wagner B, et al. Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR Am J Neuroradiol 2001 Feb; 22: 366-372.